ALKBH5 and breast carcinoma: Under hypoxia, the expression of ALKBH5 in breast cancer cells was up-regulated by hypoxia-inducible factor, which resulted in a decrease in the m6A modification level of NANOG mRNA, which in turn increased the NANOG protein level and promoted the enrichment of breast cancer stem cells (56).